Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy

癌症免疫疗法 免疫疗法 连接器 癌症研究 体内 免疫系统 体外 信使核糖核酸 化学 分子生物学 生物 免疫学 生物化学 基因 生物技术 操作系统 计算机科学
作者
Yuhao Jiang,Yanhao Zhang,Chao Liu,Jinyu Liu,Wenliang Xue,Zihao Wang,Xinsong Li
出处
期刊:Journal of Controlled Release [Elsevier BV]
卷期号:368: 663-675 被引量:13
标识
DOI:10.1016/j.jconrel.2024.03.016
摘要

Interleukin-2 (IL-2) exhibits the unique capacity to modulate immune functions, potentially exerting antitumor effects by stimulating immune responses, making it highly promising for immunotherapy. However, the clinical use of recombinant IL-2 protein faces significant limitations due to its short half-life and systemic toxicity. To overcome these challenges and fully exploit IL-2's potential in tumor immunotherapy, this study reports the development of a tumor-activated IL-2 mRNA, delivered via lipid nanoparticles (LNPs). Initially, ionizable lipid U-101 derived nanoparticles (U-101-LNP) were prepared using microfluidic technology. Subsequent in vitro and in vivo delivery tests demonstrated that U-101-LNP achieved more effective transfection than the approved ALC-0315-LNP. Following this, IL-2F mRNAs, encoding fusion proteins comprising IL-2, a linker, and CD25 (IL-2Rα), were designed and synthesized through in vitro transcription. A cleavable linker, consisting of the peptide sequence SGRSEN↓IRTA, was selected for cleavage by matrix metalloproteinase-14 (MMP-14). IL-2F mRNA was then encapsulated in U-101-LNP to create U-101-LNP/IL-2F mRNA complexes. After optimization, assessments of expression efficiency, masking, and release characteristics revealed that IL-2F with linker C4 demonstrated superior performance. Finally, the antitumor activity of IL-2F mRNA was evaluated. The results indicated that U-101-LNP/IL-2F mRNA achieved the strongest antitumor effect, with an inhibition rate of 70.3%. Immunohistochemistry observations revealed significant expressions of IL-2, IFN-γ, and CD8, suggesting an up-regulation of immunomodulation in tumor tissues. This effect could be ascribed to the expression of IL-2F, followed by the cleavage of the linker under the action of MMP-14 in tumor tissue, which sustainably releases IL-2. H&E staining of tissues treated with U-101-LNP/IL-2F mRNA showed no abnormalities. Further evaluations indicated that the U-101-LNP/IL-2F mRNA group maintained proper levels of inflammatory factors without obvious alterations in liver and renal functions. Taken together, the U-101-LNP/IL-2F mRNA formulation demonstrated effective antitumor activity and safety, which suggests potential applicability in clinical immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wanci应助王冉冉采纳,获得30
1秒前
树小夏发布了新的文献求助10
2秒前
小吴同学完成签到,获得积分10
2秒前
赘婿应助kk_yang采纳,获得10
3秒前
成就伟祺关注了科研通微信公众号
4秒前
能干的语芙完成签到 ,获得积分10
4秒前
无欲无求傻傻完成签到,获得积分10
4秒前
4秒前
4秒前
尊敬寒松完成签到 ,获得积分10
4秒前
糊涂的麦片完成签到,获得积分10
4秒前
5秒前
5秒前
6秒前
wanci应助wangdafa采纳,获得10
6秒前
竹子co完成签到,获得积分10
6秒前
steventj完成签到,获得积分10
6秒前
yz完成签到 ,获得积分10
7秒前
朴实山兰完成签到,获得积分10
8秒前
tkkdy发布了新的文献求助10
8秒前
蓁蓁发布了新的文献求助10
8秒前
醉熏的鑫发布了新的文献求助10
9秒前
独家双层汉堡完成签到,获得积分10
9秒前
Li完成签到,获得积分10
10秒前
xcx发布了新的文献求助10
10秒前
江小小发布了新的文献求助10
11秒前
11秒前
乐乐乐乐乐乐应助大橙子采纳,获得10
11秒前
伍六七完成签到,获得积分10
12秒前
shinen发布了新的文献求助10
12秒前
文艺的又亦完成签到,获得积分10
12秒前
小蘑菇应助妍儿采纳,获得10
13秒前
14秒前
义气天真完成签到,获得积分10
14秒前
满意易蓉发布了新的文献求助10
15秒前
15秒前
303完成签到 ,获得积分10
16秒前
海阔光明完成签到,获得积分10
16秒前
酷波er应助樾苒采纳,获得10
16秒前
Bingo完成签到,获得积分10
17秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds第二卷 1200
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066